CVS Aperçu des actions
CVS Health Corporation propose des solutions de santé aux États-Unis. Plus de détails
| Score flocon de neige | |
|---|---|
| Évaluation | 6/6 |
| Croissance future | 2/6 |
| Performances passées | 1/6 |
| Santé financière | 2/6 |
| Dividendes | 5/6 |
Récompenses
Analyse des risques
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
US$103.00
FV
48.4% undervalued intrinsic discount18.02%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
17 days ago author updated this narrative
US$69.14
FV
23.1% undervalued intrinsic discount4.81%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
30users have followed this narrative
2 days ago author updated this narrative
US$62.09
FV
14.3% undervalued intrinsic discount7.00%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
about 1 month ago author updated this narrative
CVS Health Corporation Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | US$53.19 |
| Plus haut sur 52 semaines | US$83.25 |
| Plus bas sur 52 semaines | US$52.71 |
| Bêta | 0.54 |
| 1Variation sur 1 mois | -18.19% |
| Variation sur 3 mois | -8.84% |
| Variation sur 1 an | -22.70% |
| 3Variation sur 3 ans | -42.90% |
| Variation sur 5 ans | -29.37% |
| Évolution depuis l'introduction en bourse | 8,001.78% |
Nouvelles et mises à jour récentes
CVS Health: Cheap But No Signs Of Turnaround (Yet)
Nov 06CVS Health (NYSE:CVS) Has A Somewhat Strained Balance Sheet
Nov 03
Recent updates
CVS Health: Cheap But No Signs Of Turnaround (Yet)
Nov 06CVS Health (NYSE:CVS) Has A Somewhat Strained Balance Sheet
Nov 03CVS Health Stock Dip: Undervalued And Ready For A Turnaround
Oct 24CVS Health: Glenview's Activism Ramps Up Pressure On Management
Sep 30CVS Health: At Least There's A Valuable Lesson (Rating Downgrade)
Sep 10A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price
Aug 08CVS Health Q2 Earnings: CEO's Swinging Axe May Have Ended The Bear Run
Aug 07Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden
Jul 21CVS Health: A Better Investment Than Walgreens Boots Alliance
Jul 09Vltava Fund - CVS Health Corp.: Why We Sold CVS
Jul 03CVS Health: Mismanagement, Eroding Moat And Poor Momentum Make It A Sell
Jun 21The Correct Play On CVS Health
Jun 06CVS Health: Downside Movement Is Overdramatic
May 26CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity
May 15We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now
May 10CVS Health: A Terrible Earnings Report, But An Undervalued Stock
May 04CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
May 03CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot
Apr 22Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)
Apr 14CVS Health: Lookback, Management Guidance Vs. Results 2018-To-Date
Apr 10Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?
Mar 27CVS Health: Better Times Likely Ahead
Mar 12CVS Health: Lower Guidance But Risk/Reward Remains Attractive
Feb 15CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance
Feb 07CVS Health: Back In The Buy Column
Jan 21CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665
Jan 17CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength
Jan 08CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year
Jan 03Rendement pour les actionnaires
| CVS | US Healthcare | US Marché | |
|---|---|---|---|
| 7D | -4.2% | -2.5% | -0.5% |
| 1Y | -22.7% | 3.4% | 32.3% |
Rendement vs Industrie: CVS a sous-performé le secteur US Healthcare qui a rapporté 3.4 % au cours de l'année écoulée.
Rendement vs marché: CVS a sous-performé le marché US qui a rapporté 32.3 % au cours de l'année écoulée.
Volatilité des prix
| CVS volatility | |
|---|---|
| CVS Average Weekly Movement | 5.5% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.6% |
| 10% least volatile stocks in US Market | 3.0% |
Cours de l'action stable: CVS n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.
Volatilité au fil du temps: La volatilité hebdomadaire de CVS ( 5% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 1996 | 259,500 | J. Joyner | www.cvshealth.com |
CVS Health Corporation propose des solutions de santé aux États-Unis. Ses activités s'articulent autour des segments Health Care Benefits, Health Services et Pharmacy & Consumer Wellness. Le segment Health Care Benefits propose des produits d'assurance maladie traditionnels, volontaires et orientés vers le consommateur, ainsi que des services connexes.
CVS Health Corporation Résumé des fondamentaux
| CVS statistiques fondamentales | |
|---|---|
| Capitalisation boursière | US$69.33b |
| Bénéfices(TTM) | US$5.02b |
| Recettes(TTM) | US$367.25b |
13.3x
Ratio P/E0.2x
Ratio P/SLe site CVS est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| CVS compte de résultat (TTM) | |
|---|---|
| Recettes | US$367.25b |
| Coût des recettes | US$316.53b |
| Marge brute | US$50.71b |
| Autres dépenses | US$45.70b |
| Les revenus | US$5.02b |
Derniers bénéfices déclarés
Sep 30, 2024
Prochaine date de publication des résultats
s/o
| Résultat par action (EPS) | 3.99 |
| Marge brute | 13.81% |
| Marge bénéficiaire nette | 1.37% |
| Ratio dettes/capitaux propres | 85.4% |
Quelles ont été les performances à long terme de CVS?
Voir les performances historiques et les comparaisons